PETGO CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 975 JPY | +0.31% |
|
+5.18% | -22.25% |
| 2023 | Petgo Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2022 | Certain Common Stock of Petgo Corporation are subject to a Lock-Up Agreement Ending on 24-OCT-2022. | CI |
| Sales 2024 | 9.9B 63.64M | Sales 2025 * | 11.16B 71.7M | Capitalization | 1.81B 11.6M |
|---|---|---|---|---|---|
| Net income 2024 | 172M 1.11M | Net income 2025 * | 218M 1.4M | EV / Sales 2024 | 0.17 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.16 x |
| P/E ratio 2024 |
9.75
x | P/E ratio 2025 * |
8.28
x | Employees | 52 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.18% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.31% | ||
| 1 week | +5.18% | ||
| Current month | +2.52% | ||
| 1 month | +11.05% | ||
| 3 months | +7.14% | ||
| 6 months | -22.74% | ||
| Current year | -22.25% |
1 week
912.00
986.00
1 month
876.00986.00
Current year
843.001 269.00
1 year
843.001 667.00
3 years
676.001 768.00
5 years
676.001 768.00
10 years
676.001 768.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hiroshi Kurosawa
FOU | Founder | 53 | 04-11-16 |
Yasushi Okubo
ADM | Chief Administrative Officer | - | 17-09-30 |
Fumihiko Koide
CTO | Chief Tech/Sci/R&D Officer | 45 | 06-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Kurosawa
FOU | Founder | 53 | 04-11-16 |
Fumihiko Koide
CTO | Chief Tech/Sci/R&D Officer | 45 | 06-07-31 |
Tomonori Fujike
BRD | Director/Board Member | 56 | 08-05-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-05 | 975 | +0.31% | 13 600 |
| 24-06-04 | 972 | -0.21% | 8,400 |
| 24-06-03 | 974 | +2.42% | 5,900 |
| 24-05-31 | 951 | +1.28% | 5,500 |
| 24-05-30 | 939 | +1.29% | 13,300 |
Delayed Quote Japan Exchange, June 05, 2024 at 12:51 am EDT
More quotes
Petgo Corp is a Japan-based company mainly engaged in the pet healthcare business and related services. The Company operates pet healthcare business centered on e-commerce. The Company is engaged in the sale of pet healthcare products for dogs and cats through its own online site petgo and several other companies' online malls. The Company is mainly engaged in the sale of veterinary drugs, dietary foods, and supplements that are sold only at animal hospitals. The main medicines include flea and tick repellents, eye drops, dermatitis, external otitis medicine, gastrointestinal medicine and others. Other pet health care products include general nutrition foods, supplements and care products.
Sector
Other Specialty Retailers
Calendar
2024-08-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.25% | 11.66M | |
| +0.31% | 1.89B | |
| +12.04% | 1.88B | |
| -7.26% | 1.39B | |
| +26.11% | 1.09B | |
| -5.25% | 899M | |
| -6.33% | 316M | |
| -17.48% | 304M | |
| +62.63% | 230M | |
| +1.07% | 105M |
- Stock Market
- Equities
- 7140 Stock
